Vitamin B2 (Riboflavin) — Research Profile

Riboflavin at 400 mg daily is believed to prevent migraines by improving mitochondrial energy metabolism in brain cells. Migraine sufferers often show impaired mitochondrial function, and riboflavin (as FAD) is essential for the electron transport chain. A landmark RCT found it reduced migraine frequency by 50% in 59% of patients. Effects typically take 2-3 months to develop.

Riboflavin (vitamin B2) has a naturally bright yellow-orange color. Because it is water-soluble, excess amounts beyond what the body needs are rapidly excreted by the kidneys, turning urine bright fluorescent yellow. This is completely harmless and simply indicates the vitamin is being absorbed and processed normally.

Standard riboflavin must be converted to riboflavin-5-phosphate (R5P, also called FMN) in the body before it can be used as a coenzyme. R5P supplements skip this conversion step, which may benefit people with impaired conversion. However, for most people, standard riboflavin is effective and much more cost-efficient, especially at migraine-preventive doses of 400 mg.

The two supplemental forms are riboflavin and its phosphorylated version riboflavin-5'-phosphate (FMN), and there is no clinical evidence that one is meaningfully better absorbed or more effective when taken orally. The body converts riboflavin to its active coenzymes FMN and FAD regardless of the starting form, and uptake from any single dose is limited to about 27 mg. Choose based on price and the dose you need rather than form claims.

Riboflavin's core established role is as a precursor to the coenzymes FMN and FAD that drive energy metabolism, and adequate intake prevents or reverses deficiency (ariboflavinosis), whose signs include angular cracks at the mouth, sore throat, and inflamed eyes. Beyond correcting deficiency, its best-supported supplemental use is migraine prevention: a randomized controlled trial and a later systematic review found that 400 mg/day reduced migraine attack frequency, though results across studies are not uniform. Evidence for other marketed uses is limited.

The RDA is 1.3 mg/day for adult men and 1.1 mg/day for adult women, rising to 1.4 mg/day in pregnancy and 1.6 mg/day during lactation. Most people meet this from milk, yogurt, eggs, meat, and fortified grains. Migraine-prevention protocols use a far higher dose, 400 mg/day, which is a specific therapeutic amount rather than a general intake target.

No specific time of day has been shown to matter for riboflavin, so take it whenever you will remember it consistently. Because about 95% is absorbed only up to roughly 27 mg of riboflavin per meal or dose, spreading intake across the day rather than taking one very large dose captures more of it, though this has not been tested against any specific outcome. For the 400 mg migraine dose, no timing or split-dose schedule has been shown to be superior, so consistency matters more than the hour you take it.

The most common and expected effect of supplemental riboflavin is bright-yellow discoloration of the urine (flavinuria), which is harmless and simply reflects the excess being excreted. No adverse effects have been reported from high intakes, including 400 mg/day for at least three months, which is why no Tolerable Upper Intake Level was set. Because absorption is self-limiting, oral doses do not build up to toxic levels.

According to the NIH Office of Dietary Supplements, riboflavin is not known to have any clinically relevant interactions with medications. Some drugs can modestly affect riboflavin status or absorption, but these do not translate into interactions that typically require dose changes. If you take medication for a chronic condition and plan to use the 400 mg migraine dose, it is still reasonable to confirm suitability with your prescriber.

People at higher risk of shortfall benefit most: vegans and others who consume little milk or dairy, vegetarian athletes, and pregnant or lactating women with limited meat and dairy intake. Individuals with the genetic riboflavin transporter deficiency require ongoing high-dose supplementation under medical care. Separately, people with recurrent migraines may consider high-dose riboflavin as a preventive option, ideally alongside their clinician.

It depends on the goal, and no precise timeframe has been established. For correcting a dietary shortfall, adequate riboflavin intake reverses the early changes of deficiency, but the NIH Office of Dietary Supplements does not state how many days or weeks that takes. For high-dose migraine prevention, the randomized trial and a later systematic review used 400 mg/day over about three months; those studies report outcomes across that whole period and do not document when any reduction in attacks first appears, so no reliable onset window can be given.

Riboflavin has a wide safety margin: the Food and Nutrition Board set no Tolerable Upper Intake Level because adverse effects have not been reported even at 400 mg/day taken for at least three months. Intakes many times the RDA from food show no observable toxicity, partly because the body absorbs little from a single dose beyond about 27 mg. Data specifically documenting high-dose use for longer than a few months are limited, so open-ended megadosing is not well characterized.

No Tolerable Upper Intake Level has been established for riboflavin because no adverse effects have been documented from high intakes, including 400 mg/day for three months or more. Absorption is self-limiting, with little taken up from any single dose above roughly 27 mg, so excess is largely excreted in urine. The most noticeable consequence of a large dose is bright-yellow urine, which is harmless.

There are no reported harmful combinations with riboflavin, and it is commonly included in B-complex and multivitamin products. Riboflavin is metabolically linked to other B vitamins, since it is needed to convert vitamin B6 to its active form and to help produce niacin from tryptophan. If you already take a B-complex or fortified foods, add a separate high-dose riboflavin product only when targeting a specific goal such as migraine prevention.

Check the label for the amount of elemental riboflavin per serving and match it to your purpose: a general multivitamin covers the roughly 1.1-1.3 mg daily requirement, while migraine-prevention regimens use a dedicated 400 mg product. Riboflavin is sold as plain riboflavin or as riboflavin-5'-phosphate (FMN); both are effective and there is no established advantage of one for oral supplementation. Because absorption caps out per dose, a single very large tablet is no more useful than the labeled amount.